Enabling Independent Living by Expanding Access to Home-Based Pulmonary Rehabilitation
2 other identifiers
interventional
9
1 country
1
Brief Summary
The purpose of this study is to test an existing home-based pulmonary rehab program with the addition of video chat and a capability of a Spanish version.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Mar 2021
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2020
CompletedFirst Posted
Study publicly available on registry
July 21, 2020
CompletedStudy Start
First participant enrolled
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2021
CompletedJuly 8, 2022
July 1, 2022
4 months
July 17, 2020
July 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Qualitative Interview
A Qualitative Interview will be conducted over the phone asking about the video chat experience.
Week 1
Study Arms (1)
Intervention
OTHERThis is a small study to assess the usability of video conferencing. A total of 10 patients will be enrolled, 5 of which will be Spanish speakers. All patients will test the video conferencing.
Interventions
Eligibility Criteria
You may qualify if:
- Patients must be ≥ 40 years old.
- Patients mist have a diagnosis of GOLD stage II, III, or IV COPD documented by pulmonary function testing.
- Patients must be a current or previous smoker with at least 10 pack-years of cigarette smoking.
- Be a native Spanish speaker.
You may not qualify if:
- Patients with a high likelihood of being lost to follow-up or contact (patients with active chemical dependency).
- Patients planning to move out of the state or who are not living in the healthcare area.
- Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto P Benzo
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 17, 2020
First Posted
July 21, 2020
Study Start
March 22, 2021
Primary Completion
July 30, 2021
Study Completion
July 30, 2021
Last Updated
July 8, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share